EIM Group
http://www.eimgroup.com/jahia/page2.htmlEIM Group is a fund of fund that focuses on identifying, screening, and analyzing the best fund managers in different markets and investment styles.
View Older Stories View More Recent Stories
-
Guggenheim Starts Homebuilding Stocks: TOL, MHO at Buy, KBH, MDC, RYL, DHI, NVR at Sell
-
Notable Analyst Rating Changes 06/14: CRNT, JBLU, AMLN, HIG Upgraded; AKAM, ISRG, DO, ARCL Downgraded
-
Cablevision Systems (CVC) Announces $1.37B Acquisition of Bresnan Com
-
Lionsgate (LGF) Issues Letter to Shareholders
-
CVS/Walgreen Fight Heats Up and Investors Lose
-
CVS Caremark (CVS) Announces Plan to Remove Walgreens (WAG) from PBM Pharmacy Network
-
Dendreon (DNDN) Sell-Off a Great Entry Point - Analyst
-
CVS's Pain May Be Rivals Gain (ESRX, MHS)
-
CVS Caremark (CVS) Lower After Walgreen (WAG) Walks
-
Minor Success Seen In Containing BP Oil Spill
-
U.S. Launches Civil, Criminal Probe of BP Oil Spill
-
Oppenheimer Upgrades BP plc (BP) to Outperform
-
Oppenheimer Upgraded Citigroup (C) to Outperform
-
Sequenom (SQNM): Bullish on the technology and Sequenom's prospects for commercializing T-21 in 2011 - Barclays
-
Oppenheimer Initiates Coverage on Globe Specialty Metals (GSM) with an Outperform
-
Oppenheimer Upgrades Office Depot (ODP) to Perform
-
Oppenheimer Downgrades Anadarko Petroleum (APC) to Perform
-
Morning Movers 4/29: ATSI, PRAN, RAS, IRBT, PALM, GTI Higher; PCBC, CASB, FIRE, HAR, OPWV, FICO Lower
-
Notable Analyst Rating Changes 04/23: YGE, WDC, CPHD, HSY Upgraded; VZ, DO, ASBC, NOK Downgraded
-
Morning Movers 4/23: IBNK, MBTF, CACB, STSA, ACTG, WAL, SPF Higher; ACUR, PEGA, HRZ, PXLW, OPLK, AVID Lower
-
Highlights From AAPL's Q2 Conference Call: Reported Best Non-Holiday Quarter of Revenue & Earnings Ever
-
Oppenheimer Lifts Their Price Target on General Electric (GE) to $23
-
Oppenheimer Maintains Positive Stance of General Electric (GE) Following Results
-
General Electric (GE) Q1 EPS Beat, But Sales Fall Short; Loan Loss Provisions Down Sharply
-
Morning Movers 4/14: DCAI, AEN, ABK, KLIC, HOTT Higher; RPC, CPRX, MIPI, SSN Lower
-
GE Healthcare (GE) Commences Flutemetamol Phase 3, To Present Phase 2 Data at HAI Meeting in Toronto
-
Analysts Mixed On Forest Labs (FRX) After Daxas Fail
-
Star Scientific (CIGX) Sees Morning Upside Following Analyst Highlight of Possible Alzheimer Cure
-
Ardea Biosciences (RDEA) to Offer 3.5M in Common Stock
-
Goldman Sachs (GS) Set Up For Another Earnings 'Beat', But Does It Matter?
-
Boeing (BA) to Recognize $150M, 20c/Share Income Tax Charge from Healthcare Bill
-
Daily State of the Markets 3/29: That Sinking Feeling
-
Lions Gate (LGF) Tells Icahn to Get Lost
-
Lionsgate (LGF) Calls Carl Icahn Offer "Inadequate and Coercive"
-
athenahealth (ATHN): Priced for Perfection, But Is Perfection Moving Out of Reach? Downgrade to Underperform - Oppenheimer
-
Notable Analyst Rating Changes 03/17: BLK, LNC, ADBE, GE Upgraded; FUQI, NUE, CTXS, ERIC Downgraded
-
Sensata Technologies (ST) IPO Trades Slightly Higher
-
Abbott (ABT) Agrees to Buy Facet Biotech (FACT) for $27/Share in Cash
-
Daily State of the Markets 3/9: Happy Birthday!
-
Top 10 News Items 3/1-3/5: Nonfarm Payrolls Better-Than-Expected, Greece Sells Debt in the Open Market, Ford Surpasses GM as Top US Autoseller
-
Medivation (MDVN) Plunges 70% After Alzheimer Drug Fails In Late Trials
-
Crude Carriers (CRU) Files 13.5M Share IPO; Sees Price of $19-$21
-
Needham & Company Upgrades NuVasive (NUVA) to Strong Buy
-
Corning (GLW): When Things Are Too Good to Last, They Don't - Oppenheimer
-
Oppenheimer Downgrades Corning (GLW) to Perform
-
CEL-SCI (CVM) Surging on Update for Multikine Cancer Drug and H1N1 Treatment
-
Notable Analyst Rating Changes 02/17: SNDK, HD, WFMI, ABFS Upgraded; VCLK, SNI, PAAS, CHE Downgraded
-
Oppenheimer Starts Mylan (MYL), Warner Chilcott (WCRX) at Outperform
-
Merriman Curhan Ford Initiates Coverage on Avanir Pharmaceuticals (AVNR) with a Buy; Compelling Small-Cap
-
Oppenheimer Lifts Price Target On General Electric (GE) to $20

